Literature DB >> 81655

Inosiplex for localized herpes zoster in childhood cancer patients: preliminary controlled study.

S Feldman, F A Hayes, S Chaudhary, M Ossi.   

Abstract

By multiple criteria, inosiplex-a reputed stimulator of virus-sensitized lymphocytes-had no demonstrable therapeutic effects in a preliminary controlled study of patients with localized herpes zoster and cancer. Lymphocytes from the six drug-treated patients were no more responsive to varicella-zoster antigen and phytohemagglutinin than were lymphocytes from seven patients who received a placebo.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 81655      PMCID： PMC352489          DOI： 10.1128/AAC.14.3.495

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

Review 1.  Viral infection and immunity.

Authors:  P B Dent; R P Larke
Journal:  Med Clin North Am       Date:  1972-03       Impact factor: 5.456

2.  Cellular immunity in host resistance to viral infections.

Authors:  L A Glasgow
Journal:  Arch Intern Med       Date:  1970-07

3.  Evaluation of topical polyinosinic acid-polycytidylic acid in treatment of localized herpes zoster in children with cancer: a randomized, double-blind controlled study.

Authors:  S Feldman; W T Hughes; R W Darlington; H K Kim
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

4.  Isoprinosine augmentation of phytohemagglutinin-induced lymphocyte proliferation.

Authors:  J W Hadden; E M Hadden; R G Coffey
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

5.  A viremic phase for herpes zoster in children with cancer.

Authors:  S Feldman; S Chaudary; M Ossi; E Epp
Journal:  J Pediatr       Date:  1977-10       Impact factor: 4.406

6.  Anti-herpesvirus action of isoprinosine.

Authors:  P Gordon; B Ronsen; E R Brown
Journal:  Antimicrob Agents Chemother       Date:  1974-02       Impact factor: 5.191

7.  Effect of isoprinosine against challenge with A(H3N2)-Hong Kong influenza virus in volunteers.

Authors:  S Longley; R L Dunning; R H Waldman
Journal:  Antimicrob Agents Chemother       Date:  1973-04       Impact factor: 5.191

8.  Mechanisms of recovery from a generalized viral infection: mousepox. II. Passive transfer of recovery mechanisms with immune lymphoid cells.

Authors:  R V Blanden
Journal:  J Exp Med       Date:  1971-05-01       Impact factor: 14.307

9.  Mechanisms of recovery from a generalized viral infection: mousepox. 3. Regression infectious foci.

Authors:  R V Blanden
Journal:  J Exp Med       Date:  1971-05-01       Impact factor: 14.307

10.  Mechanisms of recovery from a generalized viral infection: mousepox. I. The effects of anti-thymocyte serum.

Authors:  R V Blanden
Journal:  J Exp Med       Date:  1970-11       Impact factor: 14.307
View more
  3 in total

Review 1.  Ribavirin and inosiplex: a review of their present status in viral diseases.

Authors:  T W Chang; R C Heel
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546

Review 2.  Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  D M Campoli-Richards; E M Sorkin; R C Heel
Journal:  Drugs       Date:  1986-11       Impact factor: 9.546

Review 3.  Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases.

Authors:  Jiri Sliva; Chrysoula N Pantzartzi; Martin Votava
Journal:  Adv Ther       Date:  2019-06-05       Impact factor: 3.845
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.